Showing results (361-370 of 576) with videos related to
Sort By:
Pageof 58
Pharmacoepidemiology and Drug Safety|February 9, 2010
Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured populationPeter M Wahl, Keith Rodgers, Sebastian Schneeweiss, et al.Journal of Medicinal Chemistry|March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y14 Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine BioisosteresYoung-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.Biomaterials|September 2, 2015
Towards programming immune tolerance through geometric manipulation of phosphatidylserineReid A Roberts, Timothy K Eitas, James D Byrne, et al.Acta Haematologica|November 25, 2020
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of TransplantBachar Samra, Hagop M Kantarjian, Koji Sasaki, et al.Paraplegia|September 1, 1992
Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years agoG G Whiteneck, S W Charlifue, H L Frankel, et al.Neuroimage|September 20, 2012
Associations between white matter microstructure and infants' working memorySarah J Short, Jed T Elison, Barbara Davis Goldman, et al.Haematologica|December 10, 2020
Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemiaIman Abou Dalle, Ronald Paranal, Jabra Zarka, et al.Archives of Pediatrics & Adolescent Medicine|November 7, 2007
Developmental sequelae in preterm infants having a diagnosis of bronchopulmonary dysplasia: analysis using a severity-based classification systemElizabeth J Short, H Lester Kirchner, George R Asaad, et al.Leukemia & Lymphoma|October 25, 2022
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndromeDavid C Helfgott, Sabrina Racine-Brzostek, Kelsey J Short, et al.Blood Cancer Journal|October 21, 2025
Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALLNicholas J Short, Elias Jabbour, Walid Macaron, et al.Pageof 58